4-[(2-苯基乙酰基)氨基]丁酸 | 2937-01-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-[(2-苯基乙酰基)氨基]丁酸
• 英文名称: 4-[(phenylacetyl)amino]butanoic acid
• 英文别名: 4-(2-phenylacetamido)butanoic acid；4-(2-phenyl-acetylamino)-butyric acid；4-(2-Phenyl-acetylamino)-buttersaeure；N-phenylacetyl-4-aminobutyric acid；4-<2-Phenylacetamino>-buttersaeure；4-[(2-Phenylacetyl)amino]butanoic acid
• CAS: 2937-01-1
• 化学式: C₁₂H₁₅NO₃
• mdl: MFCD00448264
• 分子量: 221.256
• InChiKey: NIDZZEUGNIZNMR-UHFFFAOYSA-N

物化性质

• 熔点：
  93.5-94.0 °C(Solv: benzene (71-43-2))
• 沸点：
  498.9±38.0 °C(Predicted)
• 密度：
  1.171±0.06 g/cm3(Predicted)
• 溶解度：
  >33.2 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-[(2-苯基乙酰基)氨基]丁酸 在 N,N-二异丙基乙胺 、 三氟乙酸 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 8.5h， 生成 N-(4-oxo-4-(2-propylhydrazineyl)butyl)-2-phenylacetamide
  参考文献：
  名称：

  10.3390/md22060250

  摘要：

  DOI：

  10.3390/md22060250
• 作为产物：
  描述：

  苯乙酰氯 在 sodium hydroxide 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 14.5h， 生成 4-[(2-苯基乙酰基)氨基]丁酸
  参考文献：
  名称：

  10.3390/md22060250

  摘要：

  DOI：

  10.3390/md22060250

文献信息

• Agent for Preventing and Alleviating Wrinkles
  申请人：TSUNENAGA Makoto

  公开号：US20100113450A1

  公开（公告）日：2010-05-06

  The present invention provides an agent for preventing and alleviating wrinkles which has excellent effects of preventing and alleviating wrinkles formed by decreased barrier function of the skin owing to aging or photo aging, that is graphic wrinkles or linear wrinkles. The agent for preventing and alleviating wrinkles consisting of one or more compounds selected from the group consisting of gamma-aminobutyric acid derivatives represented by the following formula (1) or N,N,N-trimethyl gamma-aminobutyric acid represented by the following formula (3) and salts thereof: wherein R 1 and R 2 independently represent any of a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a benzyloxycarbonyl group, a cyclohexyl group, a cyclohexanemethyl group, a cyclohexanecarbonyl group, a guanidino group formed with nitrogen atom in the formula (1), an ureido group formed with nitrogen atom in the formula (1), and a group represented by following formula (2). Additionally, R 1 and R 2 may jointly form a piperidine ring, morpholine ring, or pyrrolidine ring. Both of R 1 and R 2 are not simultaneously a hydrogen atom.

  本发明提供了一种用于预防和缓解皮肤屏障功能下降引起的老化或光老化形成的皱纹（即图形皱纹或线性皱纹）的药剂。该药剂由以下式（1）所表示的γ-氨基丁酸衍生物或以下式（3）所表示的N，N，N-三甲基γ-氨基丁酸及其盐中的一种或多种化合物组成：其中R1和R2独立地表示氢原子，具有1至3个碳原子的烷基，苄氧羰基基团，环己基基团，环己基甲基基团，环己基羧基基团，在式（1）中的氮原子形成的鸟氨酸基团，在式（1）中的氮原子形成的尿素基团，以及以下式（2）所表示的基团。此外，R1和R2可以共同形成哌啶环，吗啉环或吡咯烷环。R1和R2都不同时为氢原子。
• WRINKLING-PREVENTING AND -MODIFYING AGENT
  申请人：Shiseido Company, Ltd.

  公开号：EP2123253A1

  公开（公告）日：2009-11-25

  The present invention provides an agent for preventing and alleviating wrinkles which has excellent effects of preventing and alleviating wrinkles formed by decreased barrier function of the skin owing to aging or photo aging, that is graphic wrinkles or linear wrinkles. The agent for preventing and alleviating wrinkles consisting of one or more compounds selected from the group consisting of gamma-aminobutyric acid derivatives represented by the following formula (1) or N,N,N-trimethyl gamma-aminobutyric acid represented by the following formula (3) and salts thereof: wherein R1 and R2 independently represent any of a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a benzyloxycarbonyl group, a cyclohexyl group, a cyclohexanemethyl group, a cyclohexanecarbonyl group, a guanidino group formed with nitrogen atom in the formula (1), an ureido group formed with nitrogen atom in the formula (1), and a group represented by following formula (2). Additionally, R1 and R2 may jointly form a piperidine ring, morpholine ring, or pyrrolidine ring. Both of R1 and R2 are not simultaneously a hydrogen atom.

  本发明提供了一种用于预防和减轻皱纹的药剂，该药剂对预防和减轻由于老化或光老化导致皮肤屏障功能降低而形成的皱纹（即图形皱纹或线性皱纹）具有极佳的效果。 这种预防和缓解皱纹的制剂由一种或多种化合物组成，这些化合物选自由下式（1）代表的γ-氨基丁酸衍生物或下式（3）代表的N,N,N-三甲基γ-氨基丁酸及其盐组成的组： 其中，R1 和 R2 独立地代表氢原子、具有 1 至 3 个碳原子的烷基、苄氧羰基、环己基、环己基甲基、环己基羰基、与式（1）中氮原子形成的胍基、与式（1）中氮原子形成的脲基以及下式（2）所代表的基团中的任意一种。此外，R1 和 R2 可共同形成哌啶环、吗啉环或吡咯烷环。R1 和 R2 不能同时为氢原子。
• [EN] TETRAHYDRONAPHTHALENE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF<br/>[FR] COMPOSÉ TÉTRAHYDRONAPHTALÈNE, COMPOSITION PHARMACEUTIQUE ET UTILISATION ASSOCIÉES<br/>[ZH] 四氢萘类化合物、其药物组合物及其用途
  申请人：[en]GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD.;[zh]广州市恒诺康医药科技有限公司

  公开号：WO2022089408A1

  公开（公告）日：2022-05-05

  一种新的四氢萘类化合物、其立体异构体、溶剂合物、或药学上可接受的盐，包含所述化合物的药物组合物，以及使用所述化合物或组合物在预防和/或治疗中枢神经性疾病中的用途，其中所述化合物具有式(I)所示结构：
• Composition containing a penem or carbapenem antibiotic
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0226304B1

  公开（公告）日：1991-08-28
• High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives
  作者：Giuseppe Romeo、Loredana Salerno、Valeria Pittalà、Maria N. Modica、Maria A. Siracusa、Luisa Materia、Michela Buccioni、Gabriella Marucci、Kenneth P. Minneman

  DOI：10.1016/j.ejmech.2014.06.057

  日期：2014.8

  A new series of high affinity ligands and antagonists for the α1D-adrenergic receptor (AR) has been discovered. New molecules present a [1]benzothieno[3,2-d]pyrimidin-2,4(1H,3H)-dione or a [1]benzothieno[3,2-d]pyrimidin-4(3H)-one scaffold and bear a 2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl moiety in the 3-position and various amide substituents in the 8-position. In binding assays at the three human cloned α1A-, α1B-, and α1D-AR subtypes, they showed high affinity values, particularly for the α1D-AR subtype. Compound 22 (RX18), N(1)-methyl-N(5)-[3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-2,4-dioxo-1,2,3,4-tetrahydro[1]benzothieno[3,2-d]pyrimidin-8-yl]-N(1)-(phenylmethyl)pentanediamide, was the most interesting in the series displaying very high affinity (pKi = 10.25) and potent antagonism (pKb = 9.15) when tested in a functional assay at the α1D-AR.